I am/have/had
I am looking for
Advanced Filters
Found 11 clinical trials
FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies
This is a Phase I dose-finding study of FT596 as monotherapy and in combination with Rituximab or Obinutuzumab in subjects with relapsed/refractory B-cell Lymphoma or Chronic Lymphocytic Leukemia. The study will consist of a dose-escalation stage and an expansion stage where participants will be enrolled into indication-specific cohorts.
lymphoid leukemia
refractory b-cell non-hodgkin lymphoma
antibody therapy
lymphoma
cyclophosphamide
- 0 views
- 16 Feb, 2024
- 3 locations
- 1
- 2